Oak Ridge Investments’s iRadimed IRMD Stock Holding History

Oak Ridge Investments’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.88M	Buy	30,172 +743	+3%	+$67.7K	0.16%	85
2026 Q1	$2.83M	Sell	29,429 -8,533	-22%	-$853K	0.19%	76
2025 Q4	$3.69M	Sell	37,962 -1,028	-3%	-$88.2K	0.22%	61
2025 Q3	$2.77M	Sell	38,990 -805	-2%	-$53.6K	0.18%	72
2025 Q2	$2.38M	Sell	39,795 -2,042	-5%	-$112K	0.17%	80
2025 Q1	$2.2M	Sell	41,837 -309	-0.7%	-$17.4K	0.18%	82
2024 Q4	$2.32M	Sell	42,146 -1,353	-3%	-$71.2K	0.18%	84
2024 Q3	$2.19M	Buy	+43,499	New	+$2.01M	0.19%	88

Other funds holding IRMD

Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return

JIC

Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

ADMI

Albert D. Mason Inc Boston, Massachusetts $176M AUM 40.3% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

KPP

Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return

SCI

Silver Coast Investments San Diego, United States $336M AUM 19.53% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Oak Ridge Investments's IRMD Position: Q2 2026 in Review

Oak Ridge Investments increased its iRadimed (IRMD) stake by 2.5% in Q2 2026, buying an estimated $67.7K and bringing the position to 30,172 shares worth $2.88M. The position accounts for 0.16% of the portfolio, ranked #85.

Oak Ridge Investments first reported a position in IRMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.69M in Q4 2025. 34 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Oak Ridge Investments held 30,172 shares of iRadimed worth $2.88M as of Q2 2026.
Oak Ridge Investments bought 743 iRadimed shares in Q2 2026, an estimated $67.7K.
iRadimed made up 0.16% of Oak Ridge Investments's portfolio in Q2 2026, its #85 holding.
Oak Ridge Investments first reported a position in iRadimed in Q3 2024 and has held it in 8 quarters since.
Oak Ridge Investments's iRadimed position peaked at $3.69M in Q4 2025.
34 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.